Genetic Technologies Genetic Technologies Gets Nasdaq Delisting Warning The Australian genomic testing company said that its American Depositary Shares have failed to meet the Nasdaq's minimum bid price requirement for continued listing. In Brief This Week: OpGen, MDxHealth, Dante Genomics, More New items for the week of Oct. 24, 2022. In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More News items for the week of July 11, 2022. Genetic Technologies Lab Gets Regulatory Approvals in US, Australia The lab has received NATA accreditation and CLIA certification, enabling the launch of the company's multi-disease risk assessment test in Australia and the US. In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More News items for the week of Jan. 17, 2022. Sep 28, 2021 Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent Aug 31, 2021 Genetic Technologies Fiscal Year 2021 Revenues Soar on COVID-19 Test Alliance Jul 19, 2021 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA for $4M Mar 4, 2021 Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix Jan 21, 2021 Genetic Technologies to Raise $6.6M in Direct Offering Dec 2, 2020 Genetic Technologies Lands Distribution Rights to Taliaz Antidepressant Drug Selection Tools Sep 2, 2020 Genetic Technologies Regains Compliance With Rules for Nasdaq Listing Jul 16, 2020 Genetic Technologies to Raise $5.1M in Direct Offering May 26, 2020 Genetic Technologies Prices $8M Public Offering Apr 20, 2020 Genetic Technologies Prices $1.4M Direct Offering Apr 1, 2020 Genetic Technologies Inks Deals to Raise A$1.8M Mar 16, 2020 Genetic Technologies Receives Nasdaq Delisting Notification May 22, 2019 Genetic Technologies Offers $1.2M in American Depositary Shares May 3, 2019 Genetic Technologies Out of Compliance With Nasdaq Listing Rules Apr 15, 2019 Genetic Technologies, TGen to Launch Genetic Tests in US Feb 1, 2019 Genetic Technologies, Cancer Centers to Study Breast Cancer Polygenic Risk Score Impact Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Aug 16, 2018 Genetic Technologies Announces Planned Chinese Joint Venture Aug 8, 2018 Genetic Technologies Inks A$20M Equity Placement Deal Jul 30, 2018 Genetic Technologies, Swisstec Ink Asian Distribution Deal Load More Breaking News Verily Awarded CDC Contract for Wastewater Surveillance Genomic Health to Pay $32.5M to Resolve Cancer Test False Claims Allegations by DOJ Vela Diagnostics Inks Japan Distribution Agreement for HIV-1 Drug Resistance Tests Coronary Artery Calcification Contributors, Potential Drug Targets Found in Cross-Ancestry GWAS Max Planck Team Uses Spatial Single-Cell Proteomics Method to Analyze Hepatocyte Heterogeneity The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.